Ajay Pandey

Specialising in post-merger integration and carve-outs across EMEA. Executed transactions on both buy and sell side with large/ mid-market ENR clients.

• Led sell-side G&A optimisation commentary to support fit for purpose valuation model for a confidential chemicals client in its potential sale of its non-core divestments across Europe and American assets (revenue ~ 6B). Have also led its operations workstream with sell-side due diligence for Day 1 and standalone model.
• Supported integration planning and building revenue synergies model for KPMG UK and Swiss integration.
• Supported multiple proposals on buy/ sell-side for various ENR clients across EMEA.

Focus on post-merger integration and carve-outs across EMEA for large and mid-market clients.

• Supported a confidential ODD for a leading UK newspaper in its potential sale to both corporate or PE houses. Managed analysing their footprint optimization, overall procurement cost base and performance and overall Capex and relative impact on EBITDA of the overall business.
• Led operational carve-out design and implementation for SABIC in its sale of its functional forms business to Advent Group around multi-user site separation, supply-chain and procurement business functions. Coached 2 junior team members with their client handling and project deliverables.
• Led supply-chain & procurement operational transformation for Network Rail's subsidiary Route Services, rationalizing their service delivery model
  and identifying potential synergies for their transition to GBR. Coached a junior team member with their client handling and project deliverables.

Focus on post-merger integration and carve-outs across large-cap ENR, FS and Life-sciences clients.

• Managed TSA exit strategy and completion of sale in APAC and EMEA regions for Cardinal Health in its sale of its Cordis business to a PE working directly with supply-chain, production and finance functional leads.
• Supported Aviva with TSA development, Day 1 costing & TSA governance in its €6.5B divestment of their insurance business across Europe to three different FIGs.
• Supported buy-side diligence for a major UK-based chemical company reviewing key operational risks, Day1 costing and TSAs/LTAs assessment for their manufacturing, supply chain and procurement business functions.

Focus on post-merger integration and carve-outs across large-cap ENR and Life-sciences clients.

• Supported buy-side assistance to synergies case for AstraZeneca in its $39B acquisition of Alexion reviewing their operational footprint and rationalizing synergies and its phasing.
• Supported central Day 1 planning and delivery team for LSEG in its $27B acquisition of Refinitiv working closely with multiple stakeholders to track and manage successful completion of their Day1 objectives.
• Provided carve-out design and implementation support on site separation, supply-chain and contracts separation to SABIC in its carve-out of its specialty chemical business.

Led a team of 6FTEs in delivering precedent transaction mandates within ENR and TMT sectors.

• Led integration of S&P Capital IQ & SNL Financial M&A dataset and combined product launch under S&P Global for their M&A comp analysis and deal tracking dataset.
• Fostered a high-performing environment to drive productivity and quality.
• Spearheaded lean innovation with implementing RPA for rationalizing valuation of FM/AM stations transacted in US market.

Led management of a global oil & gas assets database for M&A and financing deals across the globe.

• Assisted in publishing monthly E&P newsletters on oil & gas industry for Evaluate Energy focusing on M&A trends, financing support, new
  discoveries and geopolitical influence.
• Analyzed valuation of E&P assets based on M&A deals and corresponding reserve values.